A/S Genmab insider trades: Merus (MRUS) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where A/S reports to the SEC
Open-market buys and sales
2 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Dec 19, 2025 | MRUS | ↑ Buy | 278,441 | $97.00 | $27.0M | Indirect | Dec 22, 2025 (3d) |
| Dec 17, 2025 | MRUS | ↑ Buy | 271,547 | $97.00 | $26.3M | Indirect | Dec 18, 2025 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other MRUS insiders
Open-market trades in the last 12 months
About A/S Genmab's insider trades
A/S Genmab is an insider at Merus (MRUS). Since Dec 17, 2025, A/S has reported 2 open-market purchases worth $53.3M and no sales on SEC Form 4. In the last 12 months: 2 buys ($53.3M).
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every MRUS insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.